Connor, Clark & Lunn Investment Management (CC&L)’s Aehr Test Systems AEHR Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.11M	Buy	+218,809	New	+$7M	0.02%	532

Other funds holding AEHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s AEHR Position: Q1 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) opened a new position in Aehr Test Systems (AEHR) in Q1 2026: 218,809 shares worth $8.11M. The stake represents 0.02% of the portfolio and ranks #532 among its holdings.

191 funds tracked by Wall St. Rank hold AEHR as of Q1 2026.

Connor, Clark & Lunn Investment Management (CC&L) held 218,809 shares of Aehr Test Systems worth $8.11M as of Q1 2026.
Aehr Test Systems was a new Connor, Clark & Lunn Investment Management (CC&L) position in Q1 2026.
Aehr Test Systems made up 0.02% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q1 2026, its #532 holding.
191 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2026, filed 11 May 2026.